Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Economic Times
The Economic Times
Debaroti Adhikary

Zydus Lifesciences shares fall 2% as firm acquires US-based Assertio Holdings for $166 million

The shares of Zydus Lifesciences declined 2% to Rs 1,058 on the BSE on Wednesday after the company announced that it has completed the acquisition of US-based pharma company Assertio Holdings Inc. for $166.4 million.

In an exchange filing released on Tuesday, Zydus Lifesciences said that it has successfully completed the cash tender offer through its wholly-owned subsidiary, Zara Merger Sub Inc, for all the outstanding shares of common stock of Assertio Holdings Inc.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.